HBW
WST icon

Hazlett, Burt & Watson’s West Pharmaceutical WST Stock Holding History

Hazlett, Burt & Watson’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Hold
100
– – 0.01% 517
2026
Q1 		$25K Hold
100
– – 0.01% 553
2025
Q4 		$28K Hold
100
– – 0.01% 544
2025
Q3 		$26K Hold
100
– – 0.01% 520
2025
Q2 		$22K Hold
100
– – 0.01% 490
2025
Q1 		$22K Hold
100
– – 0.01% 482
2024
Q4 		$33K Hold
100
– – 0.01% 407
2024
Q3 		$30K Hold
100
– – 0.01% 422
2024
Q2 		$33K Hold
100
– – 0.02% 392
2024
Q1 		$40K Buy
+100
New +$37K 0.02% 360

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hazlett, Burt & Watson's WST Position: Q2 2026 in Review

Hazlett, Burt & Watson held its West Pharmaceutical (WST) position steady in Q2 2026 at 100 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #517.

Hazlett, Burt & Watson first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $40K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Hazlett, Burt & Watson held 100 shares of West Pharmaceutical worth $36K as of Q2 2026.
  • Hazlett, Burt & Watson left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #517 holding.
  • Hazlett, Burt & Watson first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Hazlett, Burt & Watson's West Pharmaceutical position peaked at $40K in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.